Asia Pacific Genotyping Market Size & Outlook, 2023-2030
Asia Pacific genotyping market, 2018-2030 (US$M)
Related Markets
Asia Pacific genotyping market highlights
- The Asia Pacific genotyping market generated a revenue of USD 4,279.5 million in 2023.
- The market is expected to grow at a CAGR of 16% from 2024 to 2030.
- In terms of segment, reagents & kits was the largest revenue generating product in 2023.
- Reagents & kits is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, India is expected to register the highest CAGR from 2024 to 2030.
Asia Pacific data book summary
| Market revenue in 2023 | USD 4,279.5 million |
| Market revenue in 2030 | USD 12,067.9 million |
| Growth rate | 16% (CAGR from 2023 to 2030) |
| Largest segment | Reagents & kits |
| Fastest growing segment | Reagents & kits |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Instruments, Reagents & kits, Services |
| Key market players worldwide | Illumina Inc, Thermo Fisher Scientific Inc, Qiagen NV, Roche, Fluidigm Corporation, Danaher Corp, Agilent Technologies, Eurofins Scientific SE, GE HealthCare Technologies Inc Common Stock, Bio-Rad Laboratories Inc |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 23.9% of the global genotyping market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 12,067.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Genotyping Market Scope
Genotyping Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific genotyping market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to genotyping market will help companies and investors design strategic landscapes.
Reagents & kits was the largest segment with a revenue share of 61.18% in 2023. Horizon Databook has segmented the Asia Pacific genotyping market based on instruments, reagents & kits, services covering the revenue growth of each sub-segment from 2018 to 2030.
Asia Pacific is one of the lucrative and fastest-growing markets for genotyping due to presence of large population suffering from chronic diseases, such as cancer and genetic disorders. Hospitals receive reimbursement from governments for treatment and diagnostic tests in some of the more developed economies in Asia Pacific. Underdeveloped economies provide little to no reimbursement.
However, these countries are expected to change their guidelines over the forecast period. Improving healthcare reimbursement guidelines, presence of large target population, and high unmet diagnostic needs are expected to provide a lucrative platform for companies in this region.
Presence of key market players and introduction of technologically advanced instruments are leading to increase in the demand for genotyping products. Furthermore, rising number of initiatives being undertaken by governments to improve the health status of population is expected to drive market growth during the forecast period.
Reasons to subscribe to Asia Pacific genotyping market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific genotyping market databook
-
Our clientele includes a mix of genotyping market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific genotyping market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific genotyping market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific genotyping market size, by country, 2018-2030 (US$M)
Asia Pacific Genotyping Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
